Table 2.
Fusion gene frequencies and FAB subtypes of pediatric patients with AML.
| FAB subtypea | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fusion gene | M0 | M1 | M2 | M3 | M4 | M5 | M6 | M7 | Totalb |
| AML1-ETO | – | 3 (50%) | 9 (39.2%) | – | 4 (17.4%) | – | – | 1 (16.7%) | 17 (22.1%) |
| PML-RARA | – | – | 1 (4.3%) | 12 (85.7%) | 3 (13.1%) | – | – | – | 16 (20.8%) |
| CBFB-MYH11 | – | – | 1 (4.3%) | – | 2 (8.7%) | 1 (50%) | – | – | 4 (5.2%) |
| BCR-ABL1p210 | – | – | 1 (4.3%) | – | 1 (4.3%) | – | – | – | 2 (2.6%) |
| MLL-AF9 | – | – | – | – | – | – | – | – | – |
| Not detected | 2 (100%) | 3 (50%) | 11 (47.9%) | 2 (14.3%) | 13 (56.5%) | 1 (50%) | 1 (100%) | 5 (83.3%) | 38 (49.3%) |
a
Frequencies regarding FAB subtypes.
b
Frequencies regarding total samples.